Ropes & Gray is leading the way on Cubist Pharmaceuticals's acquisitions of Trius Therapeutics and Optimer Pharmaceuticals in deals with a combined value of up to $1.62 billion combined. Trius and Optimer turned to Cooley and Sullivan & Cromwell, respectively.
Ropes, Cooley, S&C Help Draw Up Cubist Drug Deals
The Am Law Daily
July 31, 2013